HALOZYME THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Halozyme Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $12.6M, a 34.3% increase year-over-year.
  • Halozyme Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.6M, a 21.7% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $36.6M, a 50.1% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.4M, a 17.2% increase from 2021.
  • Halozyme Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $20.8M, a 21% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $41.6M $12.6M +$3.21M +34.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $38.4M $9.47M -$151K -1.57% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $38.5M $9.87M +$1.91M +24% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $36.6M $9.67M +$2.44M +33.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $34.2M $9.37M +$2.57M +37.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $31.6M $9.62M +$3.99M +70.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $27.6M $7.97M +$3.22M +68% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $24.4M $7.22M +$2.1M +40.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $22.3M $6.8M +$1.4M +25.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $20.9M $5.64M +$263K +4.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $20.6M $4.74M -$181K -3.68% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $20.8M $5.13M +$930K +22.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $19.9M $5.4M +$1.18M +27.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $18.7M $5.37M +$1.12M +26.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $17.6M $4.92M +$392K +8.65% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $17.2M $4.2M -$3.03M -42% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $20.2M $4.22M -$4.02M -48.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $24.3M $4.26M -$5.58M -56.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $29.8M $4.53M -$4.94M -52.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $34.8M $7.23M -$1.78M -19.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $36.6M $8.24M -$628K -7.08% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $37.2M $9.83M +$355K +3.75% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $36.8M $9.48M +$1.14M +13.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $35.7M $9.01M +$1.61M +21.8% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $34.1M $8.87M +$1.11M +14.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $33M $9.48M +$1.29M +15.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $31.7M $8.34M +$1.02M +14% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $30.7M $7.4M +$660K +9.79% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $30M $7.76M +$1.11M +16.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $28.9M $8.19M +$1.82M +28.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $27.1M $7.32M +$1.5M +25.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $25.6M $6.74M +$1.49M +28.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-21
Q3 2016 $24.1M $6.66M +$1.1M +19.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $23M $6.37M +$466K +7.89% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $22.5M $5.82M +$1.69M +40.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $20.8M $5.25M +$1.04M +24.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-20
Q3 2015 $19.8M $5.55M +$1.38M +33% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $18.4M $5.91M +$2.31M +64.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $16.1M $4.13M +$835K +25.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $15.3M $4.21M +$1.81M +75.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $13.5M $4.18M +$1.87M +81.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $11.6M $3.59M +$1.16M +47.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $10.4M $3.3M +$898K +37.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $9.54M $2.4M +$411K +20.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $9.13M $2.3M +$382K +19.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $8.75M $2.44M +$154K +6.74% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $8.59M $2.4M +$242K +11.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $8.35M $1.99M Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $1.92M +$165K +9.39% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 $2.29M +$1.06M +86.1% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $2.15M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q3 2011 $1.76M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $1.23M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.